Nasdaq CM: RVPH REVIVA PHARMACEUTICALS TO PRESENT AT THE 2023 BIO CEO AND INVESTOR CONFERENCE ON FEBRUARY 6, 2023 View Press Release Overview Press Releases Events & Presentations Events Corporate Presentation Stock Data Stock Quote & Chart Analyst Coverage Financials & Filings SEC Filings Quarterly Results Governance Documents & Charters Committee Composition Shareholder Resources Email Alerts FAQs Governance
